Hamill John P. 4
4 · Aprea Therapeutics, Inc. · Filed Feb 27, 2023
Insider Transaction Report
Form 4
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Transactions
- Award
Common Stock
2023-02-27$5.25/sh+1,000$5,250→ 14,493 total
Footnotes (1)
- [F1]Effective February 13, 2023, the Issuer completed a 1-for-20 reverse stock split (the "Reverse Stock Split") of its outstanding Common Stock. The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.